Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

Neomorph has closed a $100 million Series B financing to [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

Emalex has secured a US patent for an orally disintegrating [...]

Currax Pharmaceuticals is highlighting a peer-reviewed publication supporting the use [...]